Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3552-3562

  Avouac, Jérôme ^a   Cagnard, Nicolas ^b   Distler, Jörg H ^c   Schoindre, Yoland ^b   Ruiz, Barbara ^b   Couraud, Pierre Olivier ^b   Uzan, Georges ^d   Boileau, Catherine ^c   Chiocchia, Gilles ^b   Allanore, Yannick ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROSTAGLANDIN SYNTHASE; STEM CELL FACTOR; TRANSCRIPTION FACTOR HOXA9; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 18; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL HYPOXIA; CELL INTERACTION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROARRAY ANALYSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN CULTURE; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

AGED; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCLERODERMA, SYSTEMIC; SKIN; STEM CELLS;

EID: 80155127962     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30536     Document Type: Article

References (38)

1. Allanore Y, Avouac J, Wipff J, Kahan A,. New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 2007; 8: 607-15. (Pubitemid 46547014)
2. Generini S, Matucci Cerinic M,. Raynaud's phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 1999; 455: 93-100. (Pubitemid 32187446)
3. Kahan A, Allanore Y,. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006; 45 Suppl 4: iv14-7. (Pubitemid 44446757)
4. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G,. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996; 98: 785-92. (Pubitemid 26349184)
5. Maurer B, Busch N, Jungel A, Pileckyte M, Gay RE, Michel BA, et al. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 2009; 120: 2367-76.
6. Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, et al. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis Rheum 2010; 62: 280-90.
7. Nguyen VA, Sgonc R, Dietrich H, Wick G,. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma). J Autoimmun 2000; 14: 143-9. (Pubitemid 30662574)
8. Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS ONE 2008; 3: e1452.
9. Romero LI, Zhang DN, Cooke JP, Ho HK, Avalos E, Herrera R, et al. Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med 2000; 5: 147-58.
10. Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008; 67: 1455-60.
11. Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y,. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 2008; 75: 131-7.
12. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009; 68: 163-8.
13. Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, et al. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum 2008; 58: 3550-61.
14. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-60. (Pubitemid 39434958)
15. Sieveking DP, Buckle A, Celermajer DS, Ng MK,. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008; 51: 660-8. (Pubitemid 351186872)
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis 1981; 31: 1-6.
17. Zhang PJ, Weber R, Liang HH, Pasha TL, LiVolsi VA,. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med 2003; 127: 1480-4. (Pubitemid 37370396)
18. Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, Zauli G,. TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 2005; 105: 3413-9. (Pubitemid 40628180)
19. Igarashi H, Cao Y, Iwai H, Piao J, Kamimura Y, Hashiguchi M, et al. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells. Biochem Biophys Res Commun 2008; 369: 1134-8.
20. Perlingeiro RC, Kyba M, Bodie S, Daley GQ,. A role for thrombopoietin in hemangioblast development. Stem Cells 2003; 21: 272-80. (Pubitemid 36623169)
21. Hristov M, Weber C,. Endothelial progenitor cells in vascular repair and remodeling. Pharmacol Res 2008; 58: 148-51.
22. Rossig L, Urbich C, Bruhl T, Dernbach E, Heeschen C, Chavakis E, et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005; 201: 1825-35. (Pubitemid 41002901)
23. Gorski DH, Walsh K,. The role of homeobox genes in vascular remodeling and angiogenesis. Circ Res 2000; 87: 865-72.
24. Trivedi CM, Patel RC, Patel CV,. Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis 2007; 195: e50-60. (Pubitemid 350087973)
25. Kamimura D, Ishihara K, Hirano T,. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149: 1-38.
26. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577-84.
27. Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G 3rd, Gerber ML, Jimenez SA, et al. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford) 2009; 48: 734-40.
28. Sfrent-Cornateanu R, Mihai C, Balan S, Ionescu R, Moldoveanu E,. The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis. J Cell Mol Med 2006; 10: 955-9.
29. Beyer C, Schett G, Gay S, Distler O, Distler JH,. Hypoxia: hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res Ther 2009; 11: 220.
30. Tinazzi E, Dolcino M, Puccetti A, Rigo A, Beri R, Valenti MT, et al. Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther 2010; 12: R131.
31. Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004; 138: 540-6. (Pubitemid 39573637)
32. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002; 4: R11.
33. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A,. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1. Arthritis Res Ther 2004; 6: R309-14.
34. Herschman HR,. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299: 125-40. (Pubitemid 26007741)
35. Dieude P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Matucci-Cerinic M, et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 2010; 69: 1958-64.
36. Vereecke L, Beyaert R, van Loo G,. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 2009; 30: 383-91.
37. Bier FF, Kleinjung F,. Feature-size limitations of microarray technology: a critical review. Fresenius J Anal Chem 2001; 371: 151-6.
38. Nadon R, Shoemaker J,. Statistical issues with microarrays: processing and analysis. Trends Genet 2002; 18: 265-71. (Pubitemid 34607142)